Company Quick10K Filing
Techcare
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-06-29
10-K 2019-12-31 Filed 2020-05-11
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-03-28
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-13
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-06-13
10-K 2016-12-31 Filed 2017-05-10
10-Q 2016-09-30 Filed 2016-12-21
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-04-04
10-Q 2015-09-30 Filed 2015-11-18
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-06
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-15
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-22
10-Q 2010-09-30 Filed 2010-12-09
8-K 2020-10-09
8-K 2020-10-06
8-K 2020-09-09
8-K 2020-08-26
8-K 2020-08-04
8-K 2020-07-29
8-K 2020-07-22
8-K 2020-06-29
8-K 2020-06-24
8-K 2020-06-15
8-K 2020-06-12
8-K 2020-06-01
8-K 2020-05-27
8-K 2020-05-11
8-K 2020-04-23
8-K 2020-04-02
8-K 2020-03-30
8-K 2020-03-18
8-K 2020-03-11
8-K 2020-03-04
8-K 2020-02-27
8-K 2020-01-15
8-K 2020-01-09
8-K 2019-10-25
8-K 2019-10-10
8-K 2019-09-20
8-K 2019-08-26
8-K 2019-07-25
8-K 2019-04-28
8-K 2019-04-25
8-K 2019-03-18
8-K 2019-02-13
8-K 2019-01-28
8-K 2019-01-22
8-K 2019-01-22
8-K 2018-12-26
8-K 2018-11-14
8-K 2018-10-10
8-K 2018-07-16
8-K 2018-03-27
8-K 2018-03-07
8-K 2018-02-21
8-K 2018-01-16

Techcare Financials

TECR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash74147111741572161696561,1191,4671,1801,10177864066284590954454384475371231126
Accounts Receivable11211121741335632
Inventory41174134156249224204198
PP&E111110000035691072910110210610014291113133227163160156
Assets781521169733912008724216562,1242,5052,1871,7891,4571,2611,0231,0598661,0007464118676023678621,3109971,1251,1581,053780667
Accounts Payable
Long-Term Debt
Liabilities8413813311113616924125029539216617313310408297206488429351253385472417460364354
Stockholders' Equity63-46-87-1154881,8842,2551,8921,3961,2911,0881,0101,0678641,000338114661114-625111,05761265374159341673
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue058711111111111143011110000277290582736
Cost of Revenue104871546333
Gross Profit1724194-363
R&D-6-2180-200000002121212913625-11001350064793562738132-590-3117143413934
SG&A-23-26-3145102982322121,4273,276236265363615-470-19-333-439287-1231,8491,733361-4641,431523435376366
Tax00000000000000000
Net Income-28-4826-48-46-102-108-93-29-1,216-3,300-231-386-449-472-514-205-295-221-456-220-8262,4013,304394-619-364-495-656-479-458406
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating74-33-36-59-76-4-48-14-32-260-1,176-240-331-59-307-320-106-297-299-484-448-328-290-405-541-505-762-320-370-345
Cash Investing-1-4-00-0-03217140-3-2-2-16-1-0-3301,122-1,178-8-40-7-1-336-1161
Cash Financing0000681807109071,6395904650123026515500-3501,146750507890090042680232225241